QuantRx Biomedical Corporation filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 USD | -.--% | -.--% | -49.37% |
1st Jan change | Capi. | |
---|---|---|
-49.37% | 315K | |
+8.78% | 219B | |
+7.31% | 183B | |
+11.22% | 133B | |
+25.50% | 108B | |
+0.91% | 63.06B | |
+12.79% | 52.02B | |
-0.62% | 48.2B | |
-0.18% | 40.37B | |
+13.19% | 39.35B |
- Stock Market
- Equities
- QTXB Stock
- News QuantRx Biomedical Corporation
- QuantRx Biomedical Corporation Auditor Raises 'Going Concern' Doubt